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Background: SAMHD1 is a triphosphohydrolase that restricts the replication of HIV-1 and SIV in myeloid cells. In
macrophages and dendritic cells, SAMHD1 restricts virus replication by diminishing the deoxynucleotide
triphosphate pool to a level below that which supports lentiviral reverse transcription. HIV-2 and related SIVs
encode the accessory protein Vpx to induce the proteasomal degradation of SAMHD1 following virus entry. While
SAMHD1 has been shown to restrict HIV-1 and SIV, the breadth of its restriction is not known and whether other
viruses have a means to counteract the restriction has not been determined.
Results: We show that SAMHD1 restricts a wide array of divergent retroviruses, including the alpha, beta and
gamma classes. Murine leukemia virus was restricted by SAMHD1 in macrophages yet removal of SAMHD1 did not
alleviate the block to infection because of an additional block to viral nuclear import. Prototype foamy virus (PFV)
and Human T cell leukemia virus type I (HTLV-1) were the only retroviruses tested that were not restricted by
SAMHD1. PFV reverse transcribes predominantly prior to entry and thus is unaffected by the dNTP level in the
target cell. It is possible that HTLV-1 has a mechanism to render the virus resistant to SAMHD1-mediated restriction.
Conclusion: The results suggest that SAMHD1 has broad anti-retroviral activity against which most viruses have not
found an escape.
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SAMHD1 is a recently identified component of the in-
nate immune system that restricts the replication of
HIV-1 in myeloid cells [1,2]. In HIV-2 and isolates of
SIV from macaques (SIVmac), the SAMHD1-mediated
restriction is counteracted by the Vpx accessory protein
[3,4] whereas in viruses such as SIVagm, the restriction
is counteracted by the related Vpr accessory protein.
HIV-1 does not encode Vpx and its Vpr does not coun-
teract SAMHD1 [1]. As a result, the virus replicates inef-
ficiently in myeloid cells. U937 cells that are stably
transduced with SAMHD1 lentiviral expression vector
and differentiated with phorbol myristic acid (PMA) are
resistant to HIV-1 and Δvpx SIV while siRNA knock-
down of SAMHD1 in primary monocyte-derived macro-
phages (MDM) increases their susceptibility to HIV-1* Correspondence: thomas.gramberg@viro.med.uni-erlangen.de; Nathaniel.
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reproduction in any medium, provided the or[1,2]. Aicardi-Goutieres Syndrome, a rare early onset
neurological disease, is in some cases caused by poly-
morphisms in the samhd1 gene that inactivate the en-
zyme. As a result of the absence of SAMHD1 the MDM
of such patients support high levels of HIV-1 replication
upon in vitro infection [5].
SAMHD1 belongs to a family of nucleases and
phosphohydrolases that are distinguished by the pres-
ence of an HD domain [6]. E. coli produced recombinant
SAMHD1 is a dGTP-stimulated triphosphohydrolase
that removes the triphosphate from deoxynucleotide tri-
phosphates (dNTPs) in a single step, converting dNTPs
to nucleosides (dNs) [7,8]. SAMHD1 was first identified
as a restriction factor in studies to identify myeloid host
proteins that coimmunoprecipitate with Vpx [1,2]. In
lentiviral-vector transduced U937 cells, SAMHD1 di-
minishes the pool of intracellular dNTPs, decreasing
their concentration to a level below that required to sup-
port reverse transcription [9]. As a result, full-length re-
verse transcripts are not generated and the infection is
blocked. In actively dividing cells, SAMHD1 has little ef-
fect on the dNTP pool [9].ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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protein that is packaged into the virion during virus as-
sembly. The packaging is mediated by an interaction
with an amino acid motif located in p6 of the Gag pre-
cursor polyprotein Pr55gag [10]. The presence of Vpx in
the virion allows it to act post-entry, prior to the synthe-
sis of new virus protein. Upon release from the virion,
Vpx is thought to form a complex with the CRL4A E3
ubiquitin ligase [11-13] that induces the ubiquitination
and proteasomal degradation of SAMHD1. The de-
creased abundance of SAMHD1 restores the dNTP pool
and releases the block to reverse transcription [9].
HIV-1 infection is sensitive to restriction by SAMHD1
yet the viral genome does not encode a Vpx protein.
Introduction of Vpx into MDM or monocyte derived
dendritic cells (MDDC) by pretreatment of the cells with
Vpx-containing virus-like particles (VLP) increases
the susceptibility of the cells to infection by HIV-1 and
HIV-1-based lentiviral vectors [14-16]. Vpx-mediated
enhancement has also been shown for feline immuno-
deficiency virus (FIV) infection and murine leukemia
virus (MLV) reverse transcription [15]. HIV-1 in which
the SIV Vpx packaging motif was engineered into Gag
p6 was shown to package Vpx provided in trans. Vpx-
containing HIV-1 was found to be nearly 100-fold more
infectious on DC than control HIV-1 [17]. Vpx does not
appear to have an effect on the ability of HIV-1 to infect
activated CD4+ T cells [18].
Nucleotide pool depletion may serve as a host defense
to protect against a variety of different viruses that are
dependent upon the dNTP pool of the target cell. This
mechanism might be particularly active against viruses
that lack Vpx or a Vpx-like function, as it is the case for
many lentiviruses and retrovirus families. To determine
which retroviruses are susceptible to SAMHD1-
mediated restriction, we tested a panel of retroviruses
for their sensitivity to restriction by SAMHD1. We
found SAMHD1 restricted all except for human T cell
leukemia virus type 1 (HTLV-1) and the prototype foamy
virus (PFV). PFV completes reverse transcription pre-
dominantly prior to virus entry, accounting for its ability
to escape SAMHD1-mediated restriction.
Results and discussion
To determine the sensitivity of diverse retroviruses to
SAMHD1-mediated restriction, we used an assay in
which SAMHD1 expressing cells were incubated with
Vpx-containing VLP and then infected with reporter
virus. This approach allowed us to analyze the effect of
Vpx on viruses that do not themselves encode or pack-
age the protein. For the assay, we generated VSV-G
pseudotyped, Vpx-containing and control VLP by trans-
fection of 293 T cells. The VLP were normalized and
then added to primary MDM and to PMA-differentiatedTHP-1 cells. THP-1 is a monocytic cell line that expresses
endogenous SAMHD1 and that in the undifferentiated
state is permissive to HIV-1 but upon differentiation with
phorbol ester becomes restricted to infection [16,18].
After addition of VLP, the cells were infected with single-
cycle reporter viruses and three days later the infection
was quantified by luciferase assay or flow cytometry in the
case of GFP and RFP reporter viruses.
Equine infectious anemia virus (EIAV) and FIV do
not encode Vpx. EIAV encodes accessory proteins of
unknown function, S2 and Ttm. Both proteins are dis-
pensable for EIAV replication in vitro and are not
virion-packaged and thus unlikely to have Vpx-like activ-
ity [19,20]. FIV encodes Vif and OrfA accessory proteins,
which were not encoded by our reporter virus. FIV Vif
serves to counteract APOBEC3 proteins [21,22] and
OrfA acts as a transactivator analogous to HIV-1 Tat
[23,24]. Neither is virion-packaged and thus not likely to
serve as a Vpx homologue. To test the susceptibility of
these viruses to SAMHD1-mediated restriction, we used
the VLP assay with EIAV and FIV reporter viruses and
an HIV-1 reporter virus control. The results showed that
HIV-1 was sensitive to SAMHD1-mediated restriction as
reflected in the nearly 10-fold boost to infectivity pro-
vided by Vpx (Figure 1A). EIAV was similarly sensitive
to SAMHD1-mediated restriction, showing a 7-fold in-
crease in response to Vpx-containing VLP, albeit at
lower virus titer (Figure 1A, 1B). FIV was similarly re-
sponsive to Vpx. The enhancement of infection by Vpx-
containing VLP in myeloid cells, like MDM or MDDC,
correlated with the ability of Vpx to degrade endogenous
SAMHD1 in these cells (Figure 1C).
To confirm these findings we generated THP-1 cell
lines in which SAMHD1 expression was knocked-down
using lentiviral vector-encoded shRNA and a control cell
line transduced with a scrambled shRNA vector. The ef-
ficiency of the SAMHD1 knock-down was confirmed by
analyzing endogenous protein levels in shControl and
shSAMHD1 cells by western blot analysis (Figure 2A).
Next, we preincubated the PMA-differentiated cells with
Vpx-containing and control VLP and infected them
with HIV-GFP. We found that the infection was re-
stricted in control cells and relieved by Vpx-containing
VLP (Figure 2B). In contrast, there was no restriction
in knock-down cells and the Vpx-VLP had no effect.
SAMHD1 knock-down was somewhat more effective
than Vpx-VLP in relieving the restriction suggesting
that virion-packaged Vpx does not fully counteract
SAMHD1. To confirm that SAMHD1 is mediating the
Vpx phenotype in THP-1 cells we reconstituted the
knock-down THP-1 cells with a lentiviral vector encod-
ing either shRNA-resistant wt SAMHD1 or a catalytic-
ally inactive mutant, SAMHD1 HD-AA, in which the







































































































Figure 1 SAMHD1 restricts lentiviral infection in myeloid cells. (A) Vpx enhances lentiviral infection in MDM. MDM were preincubated for 2 h
with Vpx-containing (+Vpx) or control VLP (−Vpx) and either not infected (mock) or infected with VSV-G-pseudotyped HIV-GFP, FIV-GFP, or EIAV-
RFP reporter virus. Reporter virus infection was quantified three days later by flow cytometry. The percentage of infected cells is shown as
average of duplicate infections. (B) FACS plot of one donor MDM infected as described in (A). (C) MDDC were incubated with Vpx-containing
VLP, control VLP or no VLP for 24. Cell lysates were prepared and analyzed on an immunoblot probed with anti-SAMHD1 MAb or anti-GAPDH
MAb. The results shown are representative of results obtained in three independent experiments.
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that knock-down cells reconstituted with wt SAMHD1,
but not with SAMHD1 HD-AA, restricted HIV-1 re-
porter virus infection again and that this restriction was
counteracted by Vpx-VLP. This gain of function was
accompanied with reduced dNTP levels in SAMHD1
cells, in sharp contrast to SAMHD1 HD-AA cells, indi-
cating that the restriction in THP-1 cells is mediated
by the nucleotide hydrolase activity of SAMHD1
(Figure 2D). To determine whether the restriction to
FIV, EIAV and SIV was also caused by SAMHD1, we
infected shControl and shSAMHD1 THP-1 cells with
the respective reporter viruses (Figure 2E-G). The re-
sults showed that the SAMHD1 knock-down relieved
the block to infection for all viruses and that Vpx-
containing VLP had no additional effect (Figure 2E-G).
We concluded that SAMHD1 is the host factor thatrestricts the infection of the lentiviruses HIV-1, SIV,
EIAV and FIV in myeloid cells.
Gamma retroviruses, such as MLV do not encode aux-
iliary genes and do not infect nondividing cells. To de-
termine whether this class of retrovirus is sensitive to
SAMHD1-mediated restriction, we tested different
strains of MLV reporter virus in the VLP assay. Different
strains of MLV were used for infection to exclude a po-
tential influence of other restriction factors, like human
TRIM5α on N-MLV infection. In this assay, Vpx-
containing VLP increased the infectivity of HIV-1 by 35-
fold as compared to control VLP on MDM (Figure 3A).
In contrast, N- and B-tropic MLV were poorly infectious
on MDM (<1% infected cells) and there was only a
minor effect of Vpx-containing VLP. To determine
whether the block to MLV infection could be saturated

































































































































Figure 2 SAMHD1 restricts HIV-1, FIV, SIV and EIAV infection in THP-1 cells. (A) Differentiated THP-1 shSAMHD1, shControl or THP-1 wild-
type cell lysates were analyzed on an immunoblot probed with anti-SAMHD1 MAb or anti-GAPDH MAb. (B) THP-1 shSAMHD1 and control cells
were differentiated with PMA, preincubated with VLP and infected with HIV-GFP reporter virus at a MOI = 1. (C) THP-1 control or shSAMHD1 cells
transduced with a lentiviral vector coding for shRNA-resistant SAMHD1, the catalytic-inactive mutant SAMHD1 HD-AA or empty vector (none),
were differentiated then pretreated with Vpx-containing or control VLP and infected with HIV-luciferase reporter virus. Luciferase activity was
measured three days postinfection and is shown as fold enhancement by Vpx-VLP treatment. (D) Quantification of dATP and dTTP nucleotide
levels in differentiated SAMHD1 knock-down and control THP-1 cell lines. In (E), (F) and (G) Control or SAMHD1 knock-down THP-1 cells were
differentiated with PMA, preincubated with Vpx-containing (+Vpx) or control VLP (−Vpx), and infected with (E) FIV-GFP, (F) with SIV-
.Delta;Vpx-luc, or (G) EIAV-RFP reporter virus. Reporter virus infection was quantified three days later by flow cytometry or luciferase assay. The
data shown are the average of triplicate infections with error bars indicating the standard deviation.

















































































Figure 3 Vpx relieves SAMHD1-mediated restriction of MLV RT but does not allow for productive infection of non-dividing cells.
(A) MDM were preincubated with Vpx-containing (+Vpx) or control VLP (−Vpx). The cells were then incubated with control supernatant (mock) or
infected with VSV-G pseudotyped HIV-GFP, N-tropic MLV-GFP (N-MLV), or B-tropic MLV (B-MLV) at a MOI = 1 or (B) with increasing amounts of
NB-tropic MLV-GFP (NB-MLV). (C) THP-1 cells that express shSAMHD1 (shSAMHD1) or control shRNA (shControl) were differentiated with PMA,
preincubated with VLP and then infected with HIV-GFP or MLV-GFP at MOI = 1. (D) MDM were incubated with Vpx-containing (+Vpx) or control
VLP (−Vpx). After 2 h, the cells were infected with control supernatant (mock) or with NB-tropic MLV reporter virus. Cellular DNA was isolated 24
and 48 h postinfection and used as a template in qPCR to amplify late reverse transcriptase products and 2-LTR circles. AZT was added to one
well treated with Vpx-containing VLP prior to infection to control for contaminating plasmid. The data are presented as the average of triplicates
with error bars indicating the standard deviation. Reporter gene expression in the infected cells was analyzed three days postinfection by flow
cytometry. Similar results were obtained in three independent experiments with different donors.
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of the cells became infected (Figure 3B) but there was
no significant effect of Vpx-containing VLP. The source
of the 5% infection is not clear, but the lack of effect of
Vpx suggests that it is the result of a small number of
contaminating lymphocytes. Knock-down of SAMHD1
in differentiated THP-1 cells also did not relieve the
block to MLV infection (Figure 3C).
Although Vpx did not relieve the block to MLV, it
remained possible that it had an effect on the ability of
the virus to reverse transcribe. To determine whether
SAMHD1 affects the reverse transcription of MLV in
MDM, we treated the cells with Vpx-containing VLP,
infected with NB-tropic MLV and then quantified the
late reverse transcripts and 2-LTR circles, a marker of
nuclear import. We found that Vpx-containing VLP sig-
nificantly enhanced the number of late reverse tran-
scripts (Figure 3D). At 24 h post-infection, the late
reverse transcripts increase about two-fold; however, if
the background is subtracted the enhancement is about
10-fold. The background in this analysis is defined by
the number of reverse transcripts measured in AZT-
treated cells and probably results from intravirionreverse transcripts. By 48 h, the number of late reverse
transcripts decreased, presumably reflecting degradation
of the viral DNA in the cytoplasm. The number of 2-
LTR circles remained low at both 24 and 48 h. Thus,
SAMHD1 restricts MLV by blocking its reverse tran-
scription yet removal of the block by Vpx does not allow
for productive infection because the virus remains un-
able to penetrate the nucleus. This finding showed that
MLV infection of MDM is restricted at two levels: re-
verse transcription and nuclear import.
Alpha retroviruses such as Rous Sarcoma Virus (RSV)
do not encode accessory proteins. Analysis of the sensi-
tivity of RSV to SAMHD1-mediated restriction showed
that the virus failed to infect MDM and that the block
was not relieved by Vpx-containing VLP (Figure 4A).
RSV also did not infect differentiated THP-1 SAMHD1
knock-down cells (Figure 4B). Analysis of the number of
reverse transcripts showed that, as for MLV, Vpx-
containing VLP relieved the block to reverse transcrip-
tion in MDM (Figure 4C).
The beta retrovirus Mason Pfizer Monkey virus (MPMV)
assembles in the cytoplasm and does not encode accessory









































































































Figure 4 SAMHD1 restricts MPMV and RSV. (A) MDM or (B) PMA-treated THP-1 shControl and THP-1 shSAMHD1 cells were preincubated with
Vpx-containing (+Vpx) or control VLP (−Vpx) and infected with control supernatant (mock) or with RSV-GFP or HIV-GFP reporter viruses at a
MOI = 1. Reporter gene expression in infected cells was analyzed three days postinfection by flow cytometry. (C) MDM were incubated with Vpx-
containing (+Vpx) or control VLP (−Vpx) and then infected with control supernatant (mock) or with RSV reporter virus. Cellular DNA was purified
24 and 48 h postinfection and used to quantify late reverse transcription products by qPCR. AZT was added to one well treated with Vpx-
containing VLP prior to infection (AZT). (D) MDM were preincubated for 2 h with Vpx-containing (+Vpx) or control VLP (−Vpx) and not infected
(mock) or infected with MPMV-GFP or HIV-GFP at a MOI = 1. The data are shown on the left as a histogram and on the right as a FACS plot.
(E) MPMV infection as in (D) but using PMA-differentiated THP-1 shControl and THP-1 shSAMHD1 cells. Reporter gene expression was analyzed
three days postinfection by flow cytometry. Reporter gene expression was analyzed as shown for HIV-GFP and MLV-GFP infection of MDM
blotted in (D). The data presented are the average of triplicates with error bars indicating the standard deviation. The results of one of three
independent experiments are shown.
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hanced its ability to infect MDM (Figure 4D) and that
knock-down of SAMHD1 in differentiated THP-1 relieved
the block to infection (Figure 4E). Thus, MPMV is sensitive
to the SAMHD1 restriction but differs from MLV and RSV
with respect to its ability to infect nondividing cells.
Foamy viruses do not encode Vpx but have the
accessory proteins Tas and Bet [25]. The viruses do not
infect nondividing cells [26]. An unusual feature of these
viruses is that they reverse transcribe late in the replica-
tion cycle [27]. As a result, many virions contain nearly
completed viral genomic DNA. To determine the sensi-
tivity of this virus to SAMHD1-mediated restriction, we
used the VLP assay with PFV-GFP reporter virus. Infect-
ivity of control HIV-GFP was enhanced 20-fold by Vpx-
containing VLP while PFV infection was unaffected
(Figure 5A). Quantitative PCR analysis of the number of
reverse transcripts in the MDM showed no effect of Vpx(Figure 5B). Addition of AZT to the target cells had no
effect on the number of reverse transcripts consistent
with the ability of PFV to complete reverse transcription
prior to infection.
HTLV-1 primarily infects T cells in vivo but at least
in vitro can infect DC and MDM [28]. Cell-free HTLV-1
particles are poorly infectious suggesting that the virus
spreads primarily by cell-to-cell contact. To determine
the sensitivity of HTLV-1 to SAMHD1-mediated restric-
tion, we used a coculture assay in which Jurkat T cells
were cotransfected with plasmids encoding the struc-
tural proteins, VSV-G and a reporter virus plasmid that
contained a luciferase gene in the antisense orientation
interrupted by an intron in the sense orientation [29].
This configuration allows the reporter gene to be
expressed in the infected cells but not in the transfected
producer cells. For the analysis, we treated MDM with
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Figure 5 Vpx does not enhance PFV infection of MDM. (A) MDM were preincubated with Vpx-containing (+Vpx) or control VLP (−Vpx) or
medium and were not infected (mock) or infected with PFV-GFP or HIV-GFP in triplicate at MOI = 1. Three days postinfection, the infected cells were
quantified by flow cytometry. One out of three independent experiments is shown. (B) MDM were incubated with Vpx-containing or control VLP or
medium (PFV) and then not infected (mock) or infected with PFV reporter virus at an MOI =1. After 24 and 48 h, cellular DNA was isolated and PFV DNA
was quantified by qPCR. AZT was added to one well treated with Vpx-containing VLP prior to infection to control for plasmid contamination (AZT). The
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Figure 6 Vpx does not enhance HTLV-1 transmission to MDM or MDDC. (A) Jurkat cells were cotransfected with an antisense-intron
-containing HTLV-1 or HIV-1 luciferase reporter plasmid, the respective packaging plasmid and pVSV-G. After 24 h, the transfected Jurkat cells
were cocultured at a ratio of 2:1 with MDM that had been preincubated for 2 h with 25 ng p27 of Vpx-containing (+Vpx) or control VLP (−Vpx).
After 48 h, the Jurkat cells were removed and adherent MDM were lysed and the luciferase activity was determined in quadruplicates.
Background luciferase activity was determined by transfection of Jurkat cells with control plasmids (mock). The data are expressed as relative light
units (RLU). One of four independent experiments is shown. (B) Jurkat cells were cotransfected with HTLV-1 or HIV-1 GFP reporter plasmids, the
respective packaging plasmid and pVSV-G. After 24 h, the transfected Jurkat cells were cocultured at a ratio of 2:1 with MDDC that had been
pretreated with 25 ng p27 of Vpx-containing (+Vpx) or control VLP (−Vpx). After 48 h, the cells were analyzed by flow cytometry to detect
transmission of HIV-1 GFP and HTLV-1 GFP from the Jurkat cells to the MDDC by staining with anti-CD3-PECy5 to detect the Jurkat cells and anti-
CD11c-APC to detect the MDDC. The infected MDDC were defined as the CD3-/CD11c + population. The data are the average of triplicate
infections with error bars to indicate the standard deviation. One of three independent experiments is shown.
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Jurkat cells by washing and measured luciferase activity
in the adherent cells. We found that there was no sig-
nificant difference in the amount of luciferase activity
between MDM pretreated with Vpx-containing and
control VLP for HTLV-1 (Figure 6A). Control HIV-1 in-
fection was enhanced 8-fold by Vpx-containing com-
pared to control VLP. To exclude the possibility of
contaminating Jurkat cells in our MDM luciferase read-
out we repeated the coculture assay described above
with Jurkat cells transfected with GFP reporter con-
structs and MDDC (Figure 6B). After 48 h of coculture,
the cells were probed with anti-CD3 and anti-CD11c
antibodies and analyzed by flow cytometry. We deter-
mined infectivity (GFP + cells) in CD3-negative CD11c-
positive MDDC and found that, in contrast to HIV, the
transmission of HTLV-1 from Jurkat T cells to MDDC
was not enhanced by Vpx (Figure 6B).
Conclusions
For most retroviruses, reverse transcription requires a
preexisting pool of dNTPs in the target cell. Thus, nu-
cleotide pool depletion by SAMHD1 could be a general
mechanism by which the cell restricts the replication of
various genera of retroviruses. Our findings show that
alpha, beta and gamma retroviruses were indeed re-
stricted by SAMHD1 in myeloid cells. These findings
are consistent with those of White et al. who recently
reported that bovine immunodeficiency virus and EIAV
are sensitive to SAMHD1 [30]. Unlike HIV-2 and SIV,
these viruses do not appear to have a mechanism to es-
cape the restriction. Two of the viruses tested were rela-
tively insensitive to SAMHD1-mediated restriction. The
foamy virus PFV completes reverse transcription pre-
dominantly prior to entry and therefore does not utilize
the target cell pool of dNTPs to synthesize its genome.
The resistance of PFV to SAMHD1-mediated restriction
did not allow the virus to productively infect MDM,
suggesting that the virus cannot penetrate the nuclear
membrane of non-mitotic cells. HTLV-1 also appeared
to be unaffected by SAMHD1. This may be because the
virus encodes an accessory protein with Vpx-like activity.
HTLV-1 encodes p8, p12, p13, p30 and HBZ accessory
proteins, one of which might have such a function [31].
However, in experiments in which HTLV-1-based VLPs
were added to target cells (Additional file 1: Figure S1)
and in which cells were transfected with HTLV-1 DNA
(Additional file 2: Figure S2), we did not detect degrad-
ation of SAMHD1 under conditions in which SIV Vpx
showed a clear effect. Thus, HTLV-1 may have another
means of avoiding SAMHD1-mediated restriction.
MLV was restricted by SAMHD1 but Vpx did not
allow the virus to infect the MDM. Although MLV did
not replicate in the MDM, Vpx relieved the block toreverse transcription. In spite of the synthesis of viral re-
verse transcripts upon Vpx-induced degradation of
SAMHD1, the lack of 2-LTR DNA circles suggests that
the virus was unable to penetrate the nucleus of the
MDM. At high MOI about 5% of the cells became
infected; however, this percentage was unaffected by
Vpx and thus unrelated to SAMHD1 and most likely
the result of low level contamination of the MDM popu-
lation with activated T cells. Our findings are inconsist-
ent with those of Kaushik et al. who found that Vpx
allowed productive infection of MDM by MLV [32]. The
source of this discrepancy is not clear.
Interestingly, once the SAMHD1-mediated block was
relieved by Vpx, MPMV infected MDM. This finding
demonstrates that the ability to navigate the nuclear
pore in nondividing cells is not limited to lentiviruses
and furthermore, that a retrovirus that lacks accessory
proteins has found a mechanism to access the nucleus
in nondividing cells. This feature does not allow MPMV
to infect myeloid cells, as the virus was still restricted by
SAMHD1, but could allow the virus to infect nondivid-
ing cell-types that have a sufficient pool of dNTPs.
The presence of Vpx in HIV-2 and SIV demonstrates
that it is possible for retroviruses to escape SAMHD1-
mediated restriction. Thus, it is somewhat surprising
that most do not encode Vpx and have no mechanism
to counteract SAMHD1. The lack of such a mechanism
may suggest that in vivo, most retroviruses do not de-
pend upon infection of myeloid cells as a means of
spreading. It has been suggested that in fact, it may be
advantageous for viruses to avoid infecting myeloid cells
because of their role in stimulating innate immune de-
fenses and in presenting processed peptide antigens to T
cells [33]. Alternatively, in species other than primates,
SAMHD1 may not play a similar role in depleting the
dNTP pool. Although nucleotide pool depletion is an
antiviral mechanism that is limited to nondividing cells
that do not need a high level of dNTPs, it is a mechan-
ism that affects a broad range of retroviruses and may
extend to other pathogens that rely upon DNA synthesis
to replicate their genomes.
Methods
Cells and cell culture
293 T cells were cultured in Dulbecco’s modified Eagle
medium / 10% fetal bovine serum (FBS). Jurkat and THP-1
cells were cultured in RPMI 1640 / 10% FBS. For THP-1
cells containing a shRNA-encoding lentiviral vector,
500 ng/ml puromycin was added to the medium. THP-1
cells were differentiated by culturing for three days with 50
nM phorbol 12-myristate 13-acetate (PMA). Monocytes
were purified from healthy donor peripheral blood mono-
nuclear cells (PBMC) by adherence to plastic or positive
selection on anti-CD14-coated magnetic beads (Miltenyi
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differentiated to MDM by culturing for 5 to 7 days in
medium containing 50 ng/ml of granulocyte-macrophage
colony-stimulating factor (GM-CSF). Monocytes were dif-
ferentiated to MDDC by culturing for four days in RPMI
1640 supplemented with 5% pooled human serum, 1 mM
HEPES, gentamycin, 50 ng/ml GM-CSF (Invitrogen) and
300 U/ml Interleukin-4 (IL-4, R&D systems)
Plasmids
Lentiviral vectors coding for short hairpin RNA target-
ing SAMHD1 (shSAMHD1) or a scrambled shRNA
(shControl) and the vector for overexpression of shRNA-
resistant wt SAMHD1 (pLenti-SAMHD1-shRNAr-neo)
have been described previously [34]. The shRNA-resistant,
catalytically inactive mutant SAMHD1 HD-AA was
cloned into pLenti-neo (Addgene) using a similar strategy.
Briefly, the HD206-207AA mutation was introduced in
shRNA-resistant SAMHD1 by overlapping PCR mutagen-
esis. The amplicon was digested with BamHI and XhoI
and cloned back into pLenti-neo via BamHI- and SalI.
The resulting construct was confirmed by nucleotide se-
quencing. The pSIVmac-luc-E- reporter constructs and
the plasmids used to generate SIV VLP, pSIV3+ and
pSIV3 + X-, have been previously described [14,16]. All
SIV-derived proviral plasmids are based on SIVmac239
with the exception of pSIV3+ and pSIV3 +X-, which are
based on SIVmac251. The env-deficient HIV-1 reporter
plasmids pNL43-E-CMVGFP expressing GFP under con-
trol of a CMV promoter and pNL-Luc3-E- expressing the
luciferase reporter gene have been described previously
[34,35]. The EGFP-expressing prototype foamy virus
(PFV) construct, pczDWP001, and the plasmid encoding
PFV Env, pczHFVenvEM02, were described previously
[36,37]. The reporter virus plasmids for FIV (pFP93 and
pGINSIN) [38,39], EIAV (pONY3.2), RSV (pAlpha.SF.
EGFP.WPRE and pcDNA.alpha.gag/pol.CO) [40], and
MPMV (pSARM-EGFP) [41,42] have been previously de-
scribed. pEIAV-RFP was a kind gift of Taichiro Takemura
and Vineet KewalRamani and was derived from p6.1
G3CeGFPW [43]. The env-deleted HTLV-1 packaging
plasmid pCMVHT1-ΔX, the intron-containing HTLV-1
luciferase reporter plasmid pCRU5HT1-inLuc, the env-de-
ficient HIV-1 packaging plasmid pCMV.PA-HIV and the
intron-containing HIV-1 luciferase reporter plasmid,
pUCHRinLuc have been described by Mazurov et al. [29].
Virus preparation and infections
Reporter viruses were produced in 293 T cells
cotransfected with env-deficient reporter virus plasmids
and pVSV-G vesicular stomatitis virus glycoprotein ex-
pression plasmid using Lipofectamine 2000 (Invitrogen)
or by calcium phosphate coprecipitation. SIVmac239-
.Delta;Vpx luciferase reporter virus (SIV-ΔVpx-luc) wasgenerated as described previously [44]. HIV-1-GFP was
generated by cotransfection of pNL43-E-CMVGFP and
pVSV-G at a mass ratio of 4:1. HIV-1-Luciferase (HIV-
luc) reporter virus was generated by cotransfection of
pNL-Luc3-E- and pVSV-G at a mass ratio of 5:1. The
EIAV reporter virus was produced by transfection of
pONY3.2, pEIAV-RFP, and pVSV-G at a ratio of 2:2:1.
FIV-ΔVif-ΔOrfA-ΔEnv-GFP reporter virus was pro-
duced by transfecting pFP93, pGINSIN, and pVSV-G at
a mass ratio of 3:3:1. MLV-GFP reporter virus (NB-tropic)
was produced by transfection with pMX-GFP, pHIT-60,
and pVSV-G at a mass ratio of 4:2:1. For the production
of N-tropic and B-tropic MLV-GFP, pHIT60 (NB-tropic
MLV gagpol) was replaced with pN-MLVgagpol or pB-
MLVgagpol in the transfection mix. RSV-EGFP reporter
virus was produced by cotransfection of the retroviral vec-
tor pAlpha.SF.EGFP.WPRE, the packaging plasmid
pcDNA.alpha.gag/pol.CO, and pVSV-G at a ratio of 2:2:1.
MPMV-GFP reporter virus was generated by transfection
with pSARM-EGFP plasmid and pVSV-G at a mass ratio
of 4:1. To generate PFV-GFP reporter virus the plasmids
pczDWP001 and pczHFVenvEM02 were cotransfected at
a mass ratio of 1:1. To produce VLP, 293 T cells were
cotransfected with pSIV3+, or pSIV3 + X-, and pVSV-G
at a mass ratio of 4:1. After 6 h, the culture medium
was replaced. Supernatants were harvested 48 h
posttransfection, passed through 0.4-μm-pore size filters,
aliquotted and frozen at −80°C.
SIV and HIV luciferase reporter viruses were normalized
on 293 T cells by luciferase assay according to the manu-
facturer’s instructions (Promega). For this, 1 X 104 293 T
cells were infected with 10, 30, and 50 μl of SIV-luc re-
porter virus. After 72 h, the infected cells were lysed and
luciferase activity was measured. The viruses had an aver-
age activity of 0.5 - 2.0 × 106 counts per second (cps)/μl.
GFP and RFP reporter viruses were titered on 293 T cells.
Infected cells were analyzed 72 h postinfection by flow cy-
tometry. VLP were normalized for SIV Gag p27 content
measured by ELISA (Innogenetics).
In reporter virus infection assays, MDM and THP-1
cells (2.5 × 105) were spin-infected in 1 ml RPMI for 2 h
at 500 × g with GFP or RFP reporter viruses at a MOI =
1 or with 4 × 105 cps of luciferase reporter viruses unless
otherwise indicated. Two hours prior to infection, the
cells were incubated with supernatant containing 25 ng
SIV-VLP in a volume of 0.5 ml RPMI. After 6 h, the
medium was replaced. The number of infected cells was
determined after three days for THP-1 or four days for
MDM by flow cytometry or luciferase assay.
Quantitative real-time PCR (qPCR)
MDM were infected at a MOI = 1 with virus stocks
treated for 1 h with 50 U of Benzonase (Invitrogen)/ml
to remove contaminating plasmid DNA. 25 μM AZT
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for residual plasmid DNA. After 24 h and 48 h, DNA
was isolated using a QIA Amp DNA Kit (Qiagen). Re-
verse transcripts in 250 ng of total DNA were quanti-
tated by qPCR with an ABI Prism 7300 (Applied
Biosystems) and SYBR green reagent (Fermentas). The
primer pairs used to detect RSV late reverse transcrip-
tion products were 50-lateRT-RSV (50-TGTGCACCT
GGGTTGATGGC) and 30-lateRT-RSV (50-TGGAGAC
AGGATCGCCACGC); for late MLV, 50-MLV-lateRT (50-
CGTCAGCGGGGGTCTTTC) and 30 MLV lateRT (50-C
TGGGCAGGGGTCTCCCG); and for MLV 2LTR cir-
cles, 50-MLV-2LTR (50-CCTCTGAGTGATTGACTAC
CC) and 30-MLV-2LTR (50-CTTAAGCTAGCTTGCCA
AACC). For PFV, the primers hybridized to a conserved
part of the pol gene that was present in the PFV plas-
mid. The primers used were PFV-sense (50-CTTCAACC
TTTGCTGAATG), PFV-antisense (50-TAATACAGGGC
TATAGGTGT) and a TaqMan probe (50-FAM-TTGGA
ATTCAGTACTCCTTATCACCC-BHQ1) [45]. Standard
curves were generated using serially diluted proviral and
2-LTR plasmids.
HTLV-1 and HIV-1 cell-to-cell transmission assay
Jurkat T cells (1 × 107 cells) were electroporated in a vol-
ume of 0.8 ml RPMI with 27.5 μg of HIV (pUCHRinLuc)
or HTLV-1 (pCRU5HT1-inLuc) intron-luciferase vec-
tors, 17.5 μg of the HIV or HTLV env-deficient pack-
aging plasmids and 5.0 μg of pVSV-G or empty vector
using a Gene Pulser Xcell (BioRad). After 24 h, the cells
were washed twice with PBS and 5 × 105 Jurkat cells in
500 μl RPMI were added on top of 2.5 × 105 MDM tar-
get cells in 1 ml RPMI. The MDM target cells were
pretreated for 2 h with 25 ng p27 of Vpx-containing or
control VLP. After 48 h of coculture, the cultures were
washed three times with PBS to remove the Jurkat cells.
The adherent MDM were then lysed and the luciferase
reporter gene activity was determined.
shRNA knockdown of SAMHD1 in THP-1 cells
Generation of THP-1 cells stably expressing control
shRNA, SAMHD1-shRNA, or both SAMHD1-shRNA
and shRNA-resistant SAMHD1 protein was described
before [34]. Complementation of THP-1 cells with cata-
lytically inactive SAMHD1 HD-AA was generated simi-
larly. Briefly, THP-1 shSAMHD1 cells were transduced
with pLenti-neo vector encoding the shRNA-resistant
SAMHD1-HD206-7AA mutant and then selected with
1.0 μg/ml puromycin and 0.4 mg/ml G418.
Immunoblot analysis
Cells were lysed in NP40 lysis buffer (50 mM HEPES,
150 mM KCl, 2 mM EDTA, 0.5% NP-40, Halt Protease
Inhibitor). Lysates were quantified by Bradford assay(BioRad). 30 μg per sample were separated by SDS-
PAGE, transferred to PVDF membranes and probed with
an anti-SAMHD1 mouse MAb (Origene), or an anti-
GAPDH mouse MAb (Ambion). The membranes were
then probed with anti-mouse horseradish peroxidase
(HRP)-labeled secondary antibody (goat, Sigma), and vi-
sualized using HRP substrate (Pierce) on an Odyssey im-
aging system (Li-Cor).Degradation assay
Degradation assays were performed as previously de-
scribed [34]. Briefly, after four days of differentiation,
MDDCs were seeded in a 24-well plate (4 × 105 cells).
The next day, the MDDCs were incubated with Vpx-
containing or control VLP for 16 h. The cells were then
lysed in NP40 lysis buffer. SAMHD1 was detected by
immunoblot analysis as described above.dNTP quantification
THP-1 shControl, THP-1 shSAMHD1, or THP-1
shSAMHD1 cells complemented with shRNA-resistant
SAMHD1 were differentiated with PMA for 20 h. Then
2 × 106 cells were lysed in 65% methanol. The levels of
dNTPs in the lysates were determined by single nucleo-
tide extension assay as described previously [46].Additional files
Additional file 1: Figure S1. HTLV-1 does not induce SAMHD1
degradation in THP-1 cells. VSV-G pseudotyped HTLV-1 virions were
produced by transfection of pCMVHT1-ΔX and pcVSV-G. A fraction of the
viral supernatant was lysed in RIPA buffer and the transfected cells were
lysed in NP40 buffer. A) SIV-VLP and HTLV virions were detected by
immunoblot analysis of the producer cells and the viral supernatant
lysates. B) SAMHD1 degradation by SIV and HTLV-1 was tested by
incubation of PMA-differentiated THP-1 cells with an increasing amount
of virus for 16h. Cells were lysed in NP40 buffer. Lysates were separated
by SDS-PAGE and SAMHD1 was detected on an immunoblot.
Additional file 2: Figure S2. HTLV-1 does not induce SAMHD1
degradation upon transfection in 293T cells. 293T cells were cotransfected
with increasing amounts of plasmids coding for (A) HA-SAMHD1 or
(B) Myc-SAMHD1, together with control vector or the indicated proviral
construct. The plasmids pSIV3+ (SIVmac) and pCMVHT1-ΔX (HTLV-1) both
encode the viral Gag, Pol and accessory proteins. After 48h, the cells were
lysed in NP40 buffer. Lysates were separated by SDS-PAGE and SAMHD1
was detected on an immunoblot.Abbreviations
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